Umbralisib FDA approval date

The FDA approved Umbralisib (TGR-1202) on 5 Feb 2021.

FDA approval date
5 Feb 2021

Drug identity checked against registry records

Also recorded as TGR-1202; UKONIQ

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-02-05DayUmbralisibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213176", "applicant_as_listed_by_fda": "TG THERAPS", "brand_names": ["UKONIQ"], "active_ingredients": ["UMBRALISIB TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210205", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026